Apogee Therapeutics, Inc. Common Stock Long-term Investment Intensity
Apogee Therapeutics, Inc. Common Stock long-term investment intensity. Apogee Therapeutics, Inc. Common Stock (APGE) has a Long-term Investment Intensity of 24.1% as of June 2026. Long-term investments of $321.94 Million represent 24.1% of total assets of $1.34 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read APGE total liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Apogee Therapeutics, Inc. Common Stock (2024–2025)
Long-term investment intensity of Apogee Therapeutics, Inc. Common Stock from 2024 to 2025. This chart shows how Apogee Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the intensity stands at 24.1%, reflecting long-term investments of $321.94 Million against total assets of $1.34 Billion USD.
Apogee Therapeutics, Inc. Common Stock Long-term Investment Intensity by Year (2024–2025)
Apogee Therapeutics, Inc. Common Stock long-term investment intensity by year from 2024 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Apogee Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Apogee Therapeutics, Inc. Common Stock asset portfolio.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 18.4% | $172.73 Million | $937.13 Million | ▼ -9.5 pp |
| 2024 | 27.9% | $210.42 Million | $753.95 Million | — |